ABL1	1	BCR-ABL1 Fusion	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	4
ABL1	1	BCR-ABL1 Fusion	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	1	BCR-ABL1 Fusion	B-Lymphoblastic Leukemia/Lymphoma	Ponatinib	1
ABL1	1	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	Bosutinib	3
ABL1	1	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	Dasatinib	2
ABL1	1	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	Imatinib	4
ABL1	1	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	1	T315I	B-Lymphoblastic Leukemia/Lymphoma	Ponatinib	3
ABL1	1	T315I	Chronic Myelogenous Leukemia	Ponatinib	3
ABL1	R1	E255K	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	E255K	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	E255K	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	E255K	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	E255V	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	E255V	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	E255V	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	E255V	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	F317C	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	F317C	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F317C	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	F317C	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F317I	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	F317I	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F317I	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	F317I	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F317L	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	1
ABL1	R1	F317L	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	F317L	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F317L	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	R1	F317L	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	F317L	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F317V	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	F317V	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F317V	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	F317V	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F359C	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F359C	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	F359C	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F359C	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	F359I	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F359I	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	F359I	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F359I	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	F359V	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	F359V	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	F359V	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	F359V	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	G250E	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	1
ABL1	R1	G250E	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	G250E	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	G250E	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	R1	G250E	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	G250E	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	R1	T315A	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	T315A	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	T315A	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	T315A	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	T315I	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib, Dasatinib, Imatinib, Bosutinib	5
ABL1	R1	T315I	Chronic Myelogenous Leukemia	Nilotinib, Dasatinib, Imatinib, Bosutinib	5
ABL1	R1	V299L	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	1
ABL1	R1	V299L	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	3
ABL1	R1	V299L	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	V299L	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	R1	V299L	Chronic Myelogenous Leukemia	Dasatinib	6
ABL1	R1	V299L	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	Y253H	B-Lymphoblastic Leukemia/Lymphoma	Imatinib	3
ABL1	R1	Y253H	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	5
ABL1	R1	Y253H	Chronic Myelogenous Leukemia	Imatinib	5
ABL1	R1	Y253H	Chronic Myelogenous Leukemia	Nilotinib	5
ABL1	2	BCR-ABL1 Fusion	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	6
ABL1	2	BCR-ABL1 Fusion	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	2
ABL1	2	E255K	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	E255K	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	E255K	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	E255K	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	2	E255V	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	E255V	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	E255V	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	E255V	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	2	F317C	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F317C	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	F317C	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F317C	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	F317I	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F317I	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	F317I	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F317I	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	F317L	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	F317L	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	F317V	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F317V	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	F317V	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F317V	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	F359C	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F359C	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	F359C	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F359C	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	2	F359I	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F359I	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	F359I	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F359I	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	2	F359V	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	F359V	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	F359V	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	F359V	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	2	T315A	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	T315A	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	T315A	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	T315A	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	V299L	B-Lymphoblastic Leukemia/Lymphoma	Nilotinib	3
ABL1	2	V299L	Chronic Myelogenous Leukemia	Nilotinib	3
ABL1	2	Y253H	B-Lymphoblastic Leukemia/Lymphoma	Bosutinib	2
ABL1	2	Y253H	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib	1
ABL1	2	Y253H	Chronic Myelogenous Leukemia	Bosutinib	2
ABL1	2	Y253H	Chronic Myelogenous Leukemia	Dasatinib	3
ABL1	3A	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	Asciminib	2
ABL2	Dx1	Fusions	B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1 Like	1
AKT1	3A	E17K	Breast Cancer	AZD5363	4
AKT1	3A	E17K	Ovarian Cancer, Endometrial Cancer	AZD5363	4
ALK	1	Fusions	Anaplastic Large-Cell Lymphoma ALK Positive	Crizotinib	3
ALK	1	Fusions	Non-Small Cell Lung Cancer	Alectinib	3
ALK	1	Fusions	Non-Small Cell Lung Cancer	Ceritinib	2
ALK	1	Fusions	Non-Small Cell Lung Cancer	Crizotinib	2
ALK	1	Oncogenic Mutations	Non-Small Cell Lung Cancer	Brigatinib	2
ALK	1	Oncogenic Mutations	Non-Small Cell Lung Cancer	Lorlatinib	4
ALK	2	Fusions	Inflammatory Myofibroblastic Tumor	Brigatinib	1
ALK	2	Fusions	Inflammatory Myofibroblastic Tumor	Ceritinib	2
ALK	2	Fusions	Inflammatory Myofibroblastic Tumor	Crizotinib	3
ALK	R2	C1156Y	Non-Small Cell Lung Cancer	Crizotinib	7
ALK	R2	G1202R	Non-Small Cell Lung Cancer	Alectinib	6
ALK	R2	G1269A	Non-Small Cell Lung Cancer	Crizotinib	6
ALK	R2	I1171N	Non-Small Cell Lung Cancer	Alectinib	7
ALK	R2	L1196M	Non-Small Cell Lung Cancer	Crizotinib	7
ARAF	2	Oncogenic Mutations	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
ARAF	2	Oncogenic Mutations	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
ARAF	2	Oncogenic Mutations	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
ARAF	3A	Oncogenic Mutations	Histiocytosis	Cobimetinib, Trametinib	1
ARAF	3A	Oncogenic Mutations	Histiocytosis	Sorafenib	2
ARAF	3A	Oncogenic Mutations	Non-Small Cell Lung Cancer	Sorafenib	1
ARID1A	4	Truncating Mutations	All Solid Tumors	PLX2853	2
ARID1A	4	Truncating Mutations	All Solid Tumors	Tazemetostat	2
ATM	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
BARD1	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
BRAF	1	V600	Erdheim-Chester Disease	Vemurafenib	2
BRAF	1	V600	Melanoma	Vemurafenib + Cobimetinib + Atezolizumab	1
BRAF	1	V600E	Anaplastic Thyroid Cancer	Dabrafenib + Trametinib	1
BRAF	1	V600E	Colorectal Cancer	Encorafenib + Cetuximab	1
BRAF	1	V600E	Melanoma	Dabrafenib	3
BRAF	1	V600E	Melanoma	Dabrafenib + Trametinib	10
BRAF	1	V600E	Melanoma	Encorafenib + Binimetinib	1
BRAF	1	V600E	Melanoma	Trametinib	4
BRAF	1	V600E	Melanoma	Vemurafenib	3
BRAF	1	V600E	Melanoma	Vemurafenib + Cobimetinib	3
BRAF	1	V600E	Non-Small Cell Lung Cancer	Dabrafenib + Trametinib	2
BRAF	1	V600K	Melanoma	Dabrafenib + Trametinib	10
BRAF	1	V600K	Melanoma	Encorafenib + Binimetinib	1
BRAF	1	V600K	Melanoma	Trametinib	4
BRAF	1	V600K	Melanoma	Vemurafenib + Cobimetinib	3
BRAF	2	Fusions	Pilocytic Astrocytoma	Selumetinib	1
BRAF	2	Oncogenic Mutations (excluding V600)	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
BRAF	2	Oncogenic Mutations (excluding V600)	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
BRAF	2	Oncogenic Mutations (excluding V600)	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
BRAF	2	Oncogenic Mutations (excluding V600E and V600K)	Melanoma	Dabrafenib + Trametinib	10
BRAF	2	Oncogenic Mutations (excluding V600E and V600K)	Melanoma	Encorafenib + Binimetinib	1
BRAF	2	Oncogenic Mutations (excluding V600E and V600K)	Melanoma	Vemurafenib + Cobimetinib	2
BRAF	2	V600	Langerhans Cell Histiocytosis	Vemurafenib, Dabrafenib	1
BRAF	2	V600E	Colorectal Cancer	Encorafenib + Panitumumab	2
BRAF	2	V600E	Diffuse Glioma	Dabrafenib + Trametinib, Vemurafenib + Cobimetinib	8
BRAF	2	V600E	Encapsulated Glioma	Vemurafenib + Cobimetinib, Dabrafenib + Trametinib	12
BRAF	2	V600E	Ganglioglioma, Pleomorphic Xanthoastrocytoma, Pilocytic Astrocytoma	Vemurafenib + Cobimetinib, Dabrafenib + Trametinib	5
BRAF	2	V600E	Hairy Cell Leukemia	Vemurafenib	1
BRAF	2	V600E	Pilocytic Astrocytoma	Selumetinib	1
BRAF	3A	Fusions	Melanoma	Cobimetinib, Trametinib	3
BRAF	3A	Fusions	Ovarian Cancer	Cobimetinib, Trametinib	2
BRAF	3A	K601	Melanoma	Trametinib	5
BRAF	3A	L597	Melanoma	Trametinib	3
BRAF	3A	Oncogenic Mutations (excluding V600)	Histiocytosis	Cobimetinib, Trametinib	1
BRAF	3A	V600	Histiocytosis	Vemurafenib, Dabrafenib	3
BRAF	3A	V600E	Biliary Tract Cancer, NOS	Dabrafenib + Trametinib	1
BRAF	4	G464	All Solid Tumors	PLX8394	5
BRAF	4	G469A	All Solid Tumors	PLX8394	5
BRAF	4	G469R	All Solid Tumors	PLX8394	5
BRAF	4	G469V	All Solid Tumors	PLX8394	5
BRAF	4	K601	All Solid Tumors	PLX8394	5
BRAF	4	L597	All Solid Tumors	PLX8394	5
BRCA1	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Niraparib	3
BRCA1	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Olaparib + Bevacizumab, Olaparib	4
BRCA1	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Rucaparib	4
BRCA1	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	2
BRCA1	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Rucaparib	2
BRCA1	3A	Oncogenic Mutations	Breast Cancer	Olaparib	2
BRCA1	3A	Oncogenic Mutations	Breast Cancer	Talazoparib	3
BRCA1	3A	Oncogenic Mutations	Pancreatic Adenocarcinoma, Acinar Cell Carcinoma of the Pancreas	Olaparib	2
BRCA2	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Niraparib	3
BRCA2	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Olaparib + Bevacizumab, Olaparib	5
BRCA2	1	Oncogenic Mutations	Ovary/Fallopian Tube, Ovarian Cancer, Peritoneal Serous Carcinoma	Rucaparib	4
BRCA2	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	2
BRCA2	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Rucaparib	2
BRCA2	3A	Oncogenic Mutations	Breast Cancer	Olaparib	2
BRCA2	3A	Oncogenic Mutations	Breast Cancer	Talazoparib	2
BRCA2	3A	Oncogenic Mutations	Pancreatic Adenocarcinoma, Acinar Cell Carcinoma of the Pancreas	Olaparib	2
BRCA2	3A	Oncogenic Mutations	Pancreatic Adenocarcinoma, Acinar Cell Carcinoma of the Pancreas	Rucaparib	3
BRIP1	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
BTK	R1	C481S	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	9
BTK	R2	C481F	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	3
BTK	R2	C481R	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	8
BTK	R2	C481Y	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	4
BTK	R2	T316A	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	2
BTK	R2	T474I	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	2
BTK	R2	T474S	Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ibrutinib	1
CDK12	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
CDK12	4	Truncating Mutations	All Solid Tumors	Pembrolizumab, Nivolumab, Cemiplimab	1
CDK4	4	Amplification	Dedifferentiated Liposarcoma, Well-Differentiated Liposarcoma	Abemaciclib, Palbociclib	2
CDKN2A	4	Oncogenic Mutations	All Solid Tumors	Abemaciclib, Palbociclib, Ribociclib	5
EGFR	1	Exon 19 deletion	Non-Small Cell Lung Cancer	Afatinib	3
EGFR	1	Exon 19 deletion	Non-Small Cell Lung Cancer	Dacomitinib	2
EGFR	1	Exon 19 deletion	Non-Small Cell Lung Cancer	Erlotinib, Erlotinib + Ramucirumab	2
EGFR	1	Exon 19 deletion	Non-Small Cell Lung Cancer	Gefitinib	6
EGFR	1	Exon 19 deletion	Non-Small Cell Lung Cancer	Osimertinib	3
EGFR	1	Exon 20 insertion	Non-Small Cell Lung Cancer	Amivantamab	1
EGFR	1	Exon 20 insertion	Non-Small Cell Lung Cancer	Mobocertinib	3
EGFR	1	G719	Non-Small Cell Lung Cancer	Afatinib	3
EGFR	1	L858R	Non-Small Cell Lung Cancer	Afatinib	3
EGFR	1	L858R	Non-Small Cell Lung Cancer	Dacomitinib	2
EGFR	1	L858R	Non-Small Cell Lung Cancer	Erlotinib, Erlotinib + Ramucirumab	2
EGFR	1	L858R	Non-Small Cell Lung Cancer	Gefitinib	6
EGFR	1	L858R	Non-Small Cell Lung Cancer	Osimertinib	3
EGFR	1	L861Q	Non-Small Cell Lung Cancer	Afatinib	6
EGFR	1	S768I	Non-Small Cell Lung Cancer	Afatinib	4
EGFR	1	T790M	Non-Small Cell Lung Cancer	Osimertinib	4
EGFR	R1	Exon 20 insertion	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	10
EGFR	R1	T790M	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	4
EGFR	2	A763_Y764insFQEA	Non-Small Cell Lung Cancer	Erlotinib	6
EGFR	3A	E709_T710delinsD	Non-Small Cell Lung Cancer	Afatinib	4
EGFR	3A	Exon 19 insertion	Non-Small Cell Lung Cancer	Erlotinib	8
EGFR	3A	Exon 19 insertion	Non-Small Cell Lung Cancer	Gefitinib	4
EGFR	3A	Exon 20 insertion	Non-Small Cell Lung Cancer	Poziotinib	3
EGFR	3A	Kinase Domain Duplication	Non-Small Cell Lung Cancer	Afatinib	3
EGFR	4	A289V	Glioma	Lapatinib	3
EGFR	4	A763_Y764insFQEA	Non-Small Cell Lung Cancer	Afatinib	1
EGFR	4	Amplification	Glioma	Lapatinib	3
EGFR	4	D761Y	Non-Small Cell Lung Cancer	Osimertinib	2
EGFR	4	Exon 19 insertion	Non-Small Cell Lung Cancer	Afatinib	1
EGFR	4	Kinase Domain Duplication	Non-Small Cell Lung Cancer	Erlotinib	4
EGFR	4	Kinase Domain Duplication	Non-Small Cell Lung Cancer	Gefitinib	3
EGFR	4	L747P	Non-Small Cell Lung Cancer	Afatinib	3
EGFR	4	R108K	Glioma	Lapatinib	3
EGFR	4	T263P	Glioma	Lapatinib	3
EGFR	R2	C797G	Non-Small Cell Lung Cancer	Osimertinib	2
EGFR	R2	C797S	Non-Small Cell Lung Cancer	Osimertinib	4
EGFR	R2	D761Y	Non-Small Cell Lung Cancer	Gefitinib	4
EGFR	R2	G724S	Non-Small Cell Lung Cancer	Osimertinib	4
ERBB2	1	Amplification	Breast Cancer	Ado-Trastuzumab Emtansine	2
ERBB2	1	Amplification	Breast Cancer	Capecitabine + Neratinib, Neratinib	4
ERBB2	1	Amplification	Breast Cancer	Chemotherapy + Pertuzumab + Trastuzumab	6
ERBB2	1	Amplification	Breast Cancer	Chemotherapy + Trastuzumab, Trastuzumab	1
ERBB2	1	Amplification	Breast Cancer	Lapatinib + Letrozole, Capecitabine + Lapatinib	2
ERBB2	1	Amplification	Breast Cancer	Margetuximab + Chemotherapy	1
ERBB2	1	Amplification	Breast Cancer	Trastuzumab Deruxtecan	1
ERBB2	1	Amplification	Breast Cancer	Tucatinib + Capecitabine + Trastuzumab	1
ERBB2	1	Amplification	Esophagogastric Cancer	Chemotherapy + Trastuzumab	1
ERBB2	1	Amplification	Esophagogastric Cancer	Pembrolizumab + Chemotherapy + Trastuzumab	1
ERBB2	1	Amplification	Esophagogastric Cancer	Trastuzumab Deruxtecan	1
ERBB2	2	Amplification	Colorectal Cancer	Lapatinib + Trastuzumab	1
ERBB2	2	Amplification	Colorectal Cancer	Pertuzumab + Trastuzumab	1
ERBB2	2	Amplification	Colorectal Cancer	Trastuzumab Deruxtecan	1
ERBB2	2	Amplification	Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma	Trastuzumab + Carboplatin-Taxol Regimen	1
ERBB2	2	Oncogenic Mutations	Non-Small Cell Lung Cancer	Ado-Trastuzumab Emtansine	3
ERBB2	2	Oncogenic Mutations	Non-Small Cell Lung Cancer	Trastuzumab Deruxtecan	1
ERBB2	3A	Oncogenic Mutations	Breast Cancer	Neratinib	3
ERBB2	3A	Oncogenic Mutations	Non-Small Cell Lung Cancer	Neratinib	2
ESR1	3A	Oncogenic Mutations	Breast Cancer	AZD9496, Fulvestrant	3
FANCL	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
FGFR1	2	Fusions	Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement	Pemigatinib	2
FGFR1	3A	Amplification	Lung Squamous Cell Carcinoma	Erdafitinib, Debio1347, Infigratinib	5
FGFR1	4	Oncogenic Mutations	All Solid Tumors	AZD4547, Erdafitinib, Debio1347, Infigratinib	8
FGFR2	1	Fusions	Bladder Cancer	Erdafitinib	2
FGFR2	1	Fusions	Cholangiocarcinoma	Infigratinib	1
FGFR2	1	Fusions	Cholangiocarcinoma	Pemigatinib	1
FGFR2	4	Oncogenic Mutations	All Solid Tumors	AZD4547, Erdafitinib, Debio1347, Infigratinib	8
FGFR3	1	Fusions	Bladder Cancer	Erdafitinib	2
FGFR3	1	G370C	Bladder Cancer	Erdafitinib	2
FGFR3	1	R248C	Bladder Cancer	Erdafitinib	2
FGFR3	1	S249C	Bladder Cancer	Erdafitinib	2
FGFR3	1	Y373C	Bladder Cancer	Erdafitinib	2
FGFR3	3A	G380R	Bladder Cancer	Erdafitinib	7
FGFR3	3A	K650	Bladder Cancer	Erdafitinib	7
FGFR3	3A	S371C	Bladder Cancer	Erdafitinib	7
FGFR3	4	Oncogenic Mutations	All Solid Tumors	AZD4547, Erdafitinib, Debio1347, Infigratinib	12
FLT3	1	D835	Acute Myeloid Leukemia	Gilteritinib	4
FLT3	1	D835	Acute Myeloid Leukemia	Midostaurin + High Dose Chemotherapy	1
FLT3	1	I836	Acute Myeloid Leukemia	Gilteritinib	4
FLT3	1	I836	Acute Myeloid Leukemia	Midostaurin + High Dose Chemotherapy	1
FLT3	1	Internal tandem duplication	Acute Myeloid Leukemia	Gilteritinib	4
FLT3	1	Internal tandem duplication	Acute Myeloid Leukemia	Midostaurin + High Dose Chemotherapy	1
FLT3	3A	Internal tandem duplication	Acute Myeloid Leukemia	Crenolanib	2
FLT3	3A	Internal tandem duplication	Acute Myeloid Leukemia	Quizartinib	4
FLT3	3A	Internal tandem duplication	Acute Myeloid Leukemia	Sorafenib	2
JAK2	2	Fusions	Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2	Ruxolitinib, Fedratinib	4
JAK2	3A	PCM1-JAK2 Fusion	Chronic Eosinophilic Leukemia, NOS	Ruxolitinib	8
KDM6A	4	Oncogenic Mutations	Bladder Cancer	Tazemetostat	3
KIT	1	A502_Y503dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	A502_Y503dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	A502_Y503dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	A502_Y503dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	A829P	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	A829P	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	A829P	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	A829P	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	C809G	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	C809G	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	C809G	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	C809G	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D572_P573dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D572_P573dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D572_P573dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D572_P573dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D572A	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D572A	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D572A	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D572A	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D579_H580insFNPTQLPYD	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D579_H580insFNPTQLPYD	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D579_H580insFNPTQLPYD	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D579_H580insFNPTQLPYD	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D579_H580insLPCD	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D579_H580insLPCD	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D579_H580insLPCD	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D579_H580insLPCD	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D579del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D579del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D579del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D579del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D816	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D816	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D816	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D816	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	D816	Mastocytosis	Avapritinib	2
KIT	1	D820	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	D820	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	D820	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	D820	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	E554_I571del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	E554_I571del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	E554_I571del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	E554_I571del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	E554_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	E554_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	E554_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	E554_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	E554_V559del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	E554_V559del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	E554_V559del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	E554_V559del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Exon 11 deletion	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Exon 11 deletion	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Exon 11 deletion	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	I563_L576del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	I563_L576del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	I563_L576del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	I563_L576del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K509I	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K509I	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K509I	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K509I	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K550_G592del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K550_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K550_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K550_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K550_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K550_V555delinsI	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K550_V555delinsI	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K550_V555delinsI	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K550_V555delinsI	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K550_W557del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K550_W557del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K550_W557del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K550_W557del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K558_E562del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K558_E562del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K558_E562del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K558_E562del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K558_V559del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K558_V559del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K558_V559del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K558_V559del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K558_V560del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K558_V560del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K558_V560del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K558_V560del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K558delinsNP	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K558delinsNP	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K558delinsNP	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K558delinsNP	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K558N	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K558N	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K558N	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K558N	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	K642E	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	K642E	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	K642E	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	K642E	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	L576del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	L576del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	L576del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	L576del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	L576P	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	L576P	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	L576P	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	L576P	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	M552_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	M552_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	M552_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	M552_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	M552_W557del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	M552_W557del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	M552_W557del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	M552_W557del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	N505I	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	N505I	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	N505I	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	N505I	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	N564_Y578del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	N564_Y578del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	N564_Y578del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	N564_Y578del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	N822	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	N822	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	N822	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	N822	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P551_E554del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P551_E554del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P551_E554del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P551_E554del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P551_M552del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P551_M552del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P551_M552del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P551_M552del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P551_V555del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P551_V555del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P551_V555del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P551_V555del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P551_W557delinsL	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P551_W557delinsL	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P551_W557delinsL	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P551_W557delinsL	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P573_D579del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P573_D579del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P573_D579del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P573_D579del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P573Q	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P573Q	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P573Q	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P573Q	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P577_D579del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P577_D579del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P577_D579del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P577_D579del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P577_R588dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P577_R588dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P577_R588dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P577_R588dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	P577_W582delinsPYD	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	P577_W582delinsPYD	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	P577_W582delinsPYD	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	P577_W582delinsPYD	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Q556_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Q556_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Q556_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Q556_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Q575_L576dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Q575_L576dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Q575_L576dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Q575_L576dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Q575_P585dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Q575_P585dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Q575_P585dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Q575_P585dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	S476I	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	S476I	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	S476I	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	S476I	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	S501_A502dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	S501_A502dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	S501_A502dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	S501_A502dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	T574_R588delinsL	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	T574_R588delinsL	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	T574_R588delinsL	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	T574_R588delinsL	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	T574insTQLPYD	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	T574insTQLPYD	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	T574insTQLPYD	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	T574insTQLPYD	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	T670I	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	T670I	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	T670I	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	T670I	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V555_L576del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V555_L576del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V555_L576del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V555_L576del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V555_V559del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V555_V559del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V555_V559del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V555_V559del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559_G565del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559_G565del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559_G565del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559_G565del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559_V560del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559_V560del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559_V560del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559_V560del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559A	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559A	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559A	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559A	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559C	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559C	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559C	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559C	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559D	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559D	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559D	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559D	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559F	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559F	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559F	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559F	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559G	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559G	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559G	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559G	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V559I	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V559I	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V559I	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V559I	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V560D	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V560D	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V560D	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V560D	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V560del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V560del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V560del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V560del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V560E	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V560E	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V560E	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V560E	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V560G	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V560G	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V560G	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V560G	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V569_L576del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V569_L576del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V569_L576del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V569_L576del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	V654A	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	V654A	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	V654A	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	V654A	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557_V559delinsC	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557_V559delinsC	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557_V559delinsC	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557_V559delinsC	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557_V560del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557_V560del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557_V560del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557_V560del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557C	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557C	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557C	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557C	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557G	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557G	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557G	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557G	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	W557R	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	W557R	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	W557R	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	W557R	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	X550_splice	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	X550_splice	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	X550_splice	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	X550_splice	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y553_K558del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y553_K558del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y553_K558del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y553_K558del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y553_Q556del	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y553_Q556del	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y553_Q556del	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y553_Q556del	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y568_L576delinsVN	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y568_L576delinsVN	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y568_L576delinsVN	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y568_L576delinsVN	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y578_D579dup	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y578_D579dup	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y578_D579dup	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y578_D579dup	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y578_D579insEQQLPY	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y578_D579insEQQLPY	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y578_D579insEQQLPY	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y578_D579insEQQLPY	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y578C	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y578C	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y578C	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y578C	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	1	Y823D	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	1	Y823D	Gastrointestinal Stromal Tumor	Regorafenib	1
KIT	1	Y823D	Gastrointestinal Stromal Tumor	Ripretinib	1
KIT	1	Y823D	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	2	A829P	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	2	C809G	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	2	D579del	Melanoma	Imatinib	2
KIT	2	D816	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	2	D820	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	2	K642E	Melanoma	Imatinib	2
KIT	2	L576del	Melanoma	Imatinib	2
KIT	2	L576P	Melanoma	Imatinib	2
KIT	2	N822	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	2	P577del	Melanoma	Imatinib	2
KIT	2	V559A	Melanoma	Imatinib	2
KIT	2	V560D	Melanoma	Imatinib	2
KIT	2	V560del	Melanoma	Imatinib	2
KIT	2	V560G	Melanoma	Imatinib	2
KIT	2	V654A	Melanoma	Imatinib	2
KIT	2	W557G	Melanoma	Imatinib	2
KIT	2	W557R	Melanoma	Imatinib	2
KIT	2	Y553_K558del	Melanoma	Imatinib	2
KIT	2	Y823D	Gastrointestinal Stromal Tumor	Sorafenib	3
KIT	4	A829P	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	A829P	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	4	C809G	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	C809G	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	4	D816	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	D816	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	4	D820	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	D820	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	4	N822	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	N822	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	4	Y823D	Gastrointestinal Stromal Tumor	Nilotinib	2
KIT	4	Y823D	Gastrointestinal Stromal Tumor	Pazopanib	1
KIT	R2	A829P	Gastrointestinal Stromal Tumor	Imatinib	3
KIT	R2	A829P	Gastrointestinal Stromal Tumor	Sunitinib	1
KIT	R2	C809G	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	C809G	Gastrointestinal Stromal Tumor	Sunitinib	4
KIT	R2	D816	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	D816	Gastrointestinal Stromal Tumor	Sunitinib	4
KIT	R2	D820	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	D820	Gastrointestinal Stromal Tumor	Sunitinib	4
KIT	R2	N822	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	N822	Gastrointestinal Stromal Tumor	Sunitinib	4
KIT	R2	T670I	Gastrointestinal Stromal Tumor	Imatinib	6
KIT	R2	V654A	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	Y823D	Gastrointestinal Stromal Tumor	Imatinib	4
KIT	R2	Y823D	Gastrointestinal Stromal Tumor	Sunitinib	4
KRAS	1	G12C	Non-Small Cell Lung Cancer	Sotorasib	1
KRAS	1	Wildtype	Colorectal Cancer	Chemotherapy + Cetuximab, Cetuximab	3
KRAS	1	Wildtype	Colorectal Cancer	Chemotherapy + Panitumumab, Panitumumab	6
KRAS	R1	Oncogenic Mutations	Colorectal Cancer	Panitumumab, Cetuximab	5
KRAS	2	Oncogenic Mutations	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
KRAS	2	Oncogenic Mutations	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
KRAS	2	Oncogenic Mutations	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
KRAS	3A	G12C	Colorectal Cancer	Cetuximab + Adagrasib, Adagrasib	1
KRAS	3A	G12C	Non-Small Cell Lung Cancer	Adagrasib	1
KRAS	3A	Oncogenic Mutations	Histiocytosis	Cobimetinib, Trametinib	1
KRAS	4	Oncogenic Mutations	All Solid Tumors	Cobimetinib, Binimetinib, Trametinib	8
MAP2K1	2	Oncogenic Mutations	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
MAP2K1	2	Oncogenic Mutations	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
MAP2K1	2	Oncogenic Mutations	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
MAP2K1	3A	Oncogenic Mutations	Histiocytosis	Cobimetinib, Trametinib	1
MAP2K1	3A	Oncogenic Mutations	Melanoma, Non-Small Cell Lung Cancer, Low-Grade Serous Ovarian Cancer	Cobimetinib, Trametinib	6
MDM2	4	Amplification	Dedifferentiated Liposarcoma, Well-Differentiated Liposarcoma	Milademetan	5
MET	1	D1010	Non-Small Cell Lung Cancer	Capmatinib	1
MET	1	D1010	Non-Small Cell Lung Cancer	Tepotinib	1
MET	1	Exon 14 deletion	Non-Small Cell Lung Cancer	Capmatinib	1
MET	1	Exon 14 deletion	Non-Small Cell Lung Cancer	Tepotinib	1
MET	1	Exon 14 splice mutation	Non-Small Cell Lung Cancer	Capmatinib	1
MET	1	Exon 14 splice mutation	Non-Small Cell Lung Cancer	Tepotinib	1
MET	2	Amplification	Non-Small Cell Lung Cancer	Crizotinib	4
MET	2	D1010	Non-Small Cell Lung Cancer	Crizotinib	6
MET	2	Exon 14 deletion	Non-Small Cell Lung Cancer	Crizotinib	6
MET	2	Exon 14 splice mutation	Non-Small Cell Lung Cancer	Crizotinib	6
MET	3A	Y1003mut	Non-Small Cell Lung Cancer	Crizotinib, Tepotinib, Capmatinib	8
MET	4	Fusions	All Solid Tumors	Crizotinib	4
MET	R2	Amplification	Non-Small Cell Lung Cancer	Erlotinib, Osimertinib, Gefitinib	5
MET	R2	D1228N	Non-Small Cell Lung Cancer	Crizotinib, Cabozantinib, Capmatinib	5
MET	R2	Y1230H	Non-Small Cell Lung Cancer	Crizotinib, Capmatinib	5
MTOR	3A	E2014K	Bladder Cancer	Everolimus	2
MTOR	3A	E2419K	Bladder Cancer	Everolimus	2
MTOR	3A	L2209V	Renal Cell Carcinoma	Temsirolimus	1
MTOR	3A	L2427Q	Renal Cell Carcinoma	Temsirolimus	1
MTOR	3A	Q2223K	Renal Cell Carcinoma	Everolimus	1
MTOR	4	Oncogenic Mutations	All Solid Tumors	Temsirolimus, Everolimus	5
NF1	1	Oncogenic Mutations	Neurofibroma	Selumetinib	2
NF1	4	Oncogenic Mutations	All Solid Tumors	Cobimetinib, Trametinib	5
NRAS	1	Wildtype	Colorectal Cancer	Chemotherapy + Panitumumab, Panitumumab	1
NRAS	R1	Oncogenic Mutations	Colorectal Cancer	Panitumumab, Cetuximab	4
NRAS	2	Oncogenic Mutations	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
NRAS	2	Oncogenic Mutations	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
NRAS	2	Oncogenic Mutations	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
NRAS	3A	Oncogenic Mutations	Histiocytosis	Cobimetinib, Trametinib	1
NRAS	3A	Oncogenic Mutations	Melanoma	Binimetinib	2
NRAS	3A	Oncogenic Mutations	Thyroid Cancer	Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol + Selumetinib	2
NRAS	4	Oncogenic Mutations	Melanoma	Binimetinib + Ribociclib	4
NRG1	3A	Fusions	All Solid Tumors	Zenocutuzumab	1
NTRK3	1	Fusions	All Solid Tumors	Entrectinib	5
NTRK3	1	Fusions	All Solid Tumors	Larotrectinib	2
NTRK3	R1	F617L	All Solid Tumors	Larotrectinib	2
NTRK3	R1	G623R	All Solid Tumors	Larotrectinib	5
NTRK3	R1	G696A	All Solid Tumors	Larotrectinib	4
PALB2	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
PDGFRA	1	Exon 18 in-frame deletions	Gastrointestinal Stromal Tumor	Avapritinib	2
PDGFRA	1	Exon 18 in-frame insertions	Gastrointestinal Stromal Tumor	Avapritinib	2
PDGFRA	1	Exon 18 missense mutations	Gastrointestinal Stromal Tumor	Avapritinib	2
PDGFRA	1	FIP1L1-PDGFRA Fusion	Chronic Eosinophilic Leukemia, NOS	Imatinib	1
PDGFRA	1	Fusions	Myelodysplastic/Myeloproliferative Neoplasms	Imatinib	8
PDGFRA	R1	D842V	Gastrointestinal Stromal Tumor	Imatinib	11
PDGFRA	2	D842V	Gastrointestinal Stromal Tumor	Dasatinib	1
PDGFRA	2	Oncogenic Mutations	Gastrointestinal Stromal Tumor	Imatinib	1
PDGFRA	2	Oncogenic Mutations	Gastrointestinal Stromal Tumor	Regorafenib	2
PDGFRA	2	Oncogenic Mutations	Gastrointestinal Stromal Tumor	Ripretinib	1
PDGFRA	2	Oncogenic Mutations	Gastrointestinal Stromal Tumor	Sunitinib	3
PIK3CA	1	C420R	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	E542K	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	E545A	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	E545D	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	E545G	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	E545K	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	H1047L	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	H1047R	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	H1047Y	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	Q546E	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	1	Q546R	Breast Cancer	Alpelisib + Fulvestrant	3
PIK3CA	2	Oncogenic Mutations (excluding C420R, E542K, E545A, E545D, E545G, E545K, Q546E, Q546R, H1047L, H1047R and H1047Y)	Breast Cancer	Alpelisib + Fulvestrant	3
PTCH1	3A	Truncating Mutations	Medulloblastoma	Sonidegib, Vismodegib	6
PTEN	4	Oncogenic Mutations	All Solid Tumors	GSK2636771, AZD8186	2
RAD51B	1	Oncogenic Mutations	Prostate Cancer, NOS, Prostate Cancer	Olaparib	1
RAF1	2	Oncogenic Mutations	Erdheim-Chester Disease	Cobimetinib, Trametinib	1
RAF1	2	Oncogenic Mutations	Langerhans Cell Histiocytosis	Cobimetinib, Trametinib	2
RAF1	2	Oncogenic Mutations	Rosai-Dorfman Disease	Cobimetinib, Trametinib	1
RAF1	3A	Oncogenic Mutations	Histiocytosis	Cobimetinib, Trametinib	1
RET	1	Fusions	Non-Small Cell Lung Cancer	Pralsetinib	1
RET	1	Fusions	Non-Small Cell Lung Cancer	Selpercatinib	2
RET	1	Fusions	Thyroid Cancer	Pralsetinib	3
RET	1	Fusions	Thyroid Cancer	Selpercatinib	1
RET	1	Oncogenic Mutations	Medullary Thyroid Cancer	Pralsetinib	3
RET	1	Oncogenic Mutations	Medullary Thyroid Cancer	Selpercatinib	1
RET	2	Fusions	Non-Small Cell Lung Cancer	Cabozantinib	3
RET	3A	Fusions	Non-Small Cell Lung Cancer	Vandetanib	1
ROS1	1	Fusions	Non-Small Cell Lung Cancer	Crizotinib	3
ROS1	1	Fusions	Non-Small Cell Lung Cancer	Entrectinib	3
SF3B1	4	Oncogenic Mutations	Acute Myeloid Leukemia	H3B-8800	2
SF3B1	4	Oncogenic Mutations	Chronic Myelomonocytic Leukemia	H3B-8800	2
SF3B1	4	Oncogenic Mutations	Myelodysplastic Syndromes	H3B-8800	2
SMARCB1	1	Deletion	Epithelioid Sarcoma	Tazemetostat	1
SMARCB1	4	Oncogenic Mutations	All Liquid Tumors	Tazemetostat	5
TSC1	1	Oncogenic Mutations	Encapsulated Glioma	Everolimus	1
